Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Methylglyoxal-Derived Nucleoside Adducts Drive Vascular Dysfunction in a RAGE-Dependent Manner

Antioxidants(2024)10.3390/antiox13010085Source: DataRank Database

Methylglyoxal-Derived Nucleoside Adducts Drive Vascular Dysfunction in a RAGE-Dependent Manner is a research paper published in Antioxidants (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.37)OA: goldTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

S. Bhattacharya ORCID,Edwin De Jesus Lopez Gonzalez ORCID,Sarah C. Shuck ORCID,Seigmund Wai Tsuen Lai ORCID

Live enrichment

PubMed:38247509 PMC:PMC10812505 OpenAlex:https://openalex.org/W4390703373

NIDDK

Grant: R21DK127285

NIDDK

Grant: P30CA033572

National Institutes of Health

Grant: 5R21DK127285-02

Epigenetic changes and methylglyoxal adducts induced by metabolic regulation in patients with type 1 diabetes that develop complications

National Institutes of Health

Grant: 5P30CA033572-27

Developmental Funds

FWCI

1.37

Citation Percentile

0.8%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2076-3921/13/1/85/pdf?version=1704870219

publisherhttps://www.mdpi.com/2076-3921/13/1/85/pdf?version=1704870219

publisherhttps://www.mdpi.com/2076-3921/13/1/85/pdf

journalhttps://doi.org/10.3390/antiox13010085

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38247509

Fields of Study

Advanced Glycation End Products researchS100 Proteins and AnnexinsNeurological Disease Mechanisms and Treatments0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

MethylglyoxalRage (emotion)NucleosideGlycationMedicinePharmacologyChemistryComputational biologyDiabetes mellitusNeuroscienceBiochemistryBiologyEndocrinologyDiabetesendothelial dysfunctionVascular diseaseEndothelial Cellsglucose metabolismReceptor For Advanced Glycation End Products (Rage)Diabetic Kidney DiseaseRM1-950ArticleTherapeutics. Pharmacology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Methylglyoxal-Derived Nucleoside Adducts Drive Vascular Dysfunction in a RAGE-Dependent Manner

FAIR Checklist

Authors (4)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)